Fonte: American Journal of Neuroradiology. Unidade: FMRP
Assuntos: DOENÇAS CEREBRAIS, BIOMARCADORES, DIAGNÓSTICO POR IMAGEM, IMAGEM POR RESSONÂNCIA MAGNÉTICA, COGNIÇÃO, PSICOMOTRICIDADE
ABNT
RAPOSO, N. et al. Peak width of skeletonized mean diffusivity as neuroimaging biomarker in cerebral amyloid angiopathy. American Journal of Neuroradiology, v. 42, n. 5, p. 875-881, 2021Tradução . . Disponível em: https://doi.org/10.3174/ajnr.A7042. Acesso em: 13 nov. 2025.APA
Raposo, N., Zotin, M. C. Z., Schoemaker, D., Xiong, L., Fotiadis, P., Charidimou, A., et al. (2021). Peak width of skeletonized mean diffusivity as neuroimaging biomarker in cerebral amyloid angiopathy. American Journal of Neuroradiology, 42( 5), 875-881. doi:10.3174/ajnr.A7042NLM
Raposo N, Zotin MCZ, Schoemaker D, Xiong L, Fotiadis P, Charidimou A, Pasi M, Boulouis G, Schwab K, Schirmer MD, Etherton MR, Gurol ME, Greenberg SM, Duering M, Viswanathan A. Peak width of skeletonized mean diffusivity as neuroimaging biomarker in cerebral amyloid angiopathy [Internet]. American Journal of Neuroradiology. 2021 ; 42( 5): 875-881.[citado 2025 nov. 13 ] Available from: https://doi.org/10.3174/ajnr.A7042Vancouver
Raposo N, Zotin MCZ, Schoemaker D, Xiong L, Fotiadis P, Charidimou A, Pasi M, Boulouis G, Schwab K, Schirmer MD, Etherton MR, Gurol ME, Greenberg SM, Duering M, Viswanathan A. Peak width of skeletonized mean diffusivity as neuroimaging biomarker in cerebral amyloid angiopathy [Internet]. American Journal of Neuroradiology. 2021 ; 42( 5): 875-881.[citado 2025 nov. 13 ] Available from: https://doi.org/10.3174/ajnr.A7042
